Speakers:

Anish Thomas, M.B.B.S., M.D. ​| Clinical Director & Acting Deputy Chief​, Developmental Therapeutics Branch, Center for Cancer Research​, National Cancer Institute

Tatiana Prowell, M.D.​ | Senior Clinical Reviewer &​ Breast Cancer Scientific Liaison, U.S. Food & Drug Admin

Krista Zanetti, Ph.D., MPH, R.D.N.​ | Program Director​, Office of Nutrition Research, NIH

Nastaran Zahir, Ph.D.​ | Acting Director, Center for Cancer Training​, Branch Director, Cancer Training Branch​, National Cancer Institute

View on site | Email this event

Skip the wait! Register in advance to reserve your preferred donation time.

View on site | Email this event

Komen Breast Cancer Forum - Jaehyuk Choi, M.D., Ph.D.

Wednesday, June 17th, 2026

Design of Next-Generation Cell Therapies

Speaker: Dr. Jaehyuk Choi, M.D., Ph.D.

Director of the Center for Cellular Therapies and Cancer Immunology

Simmons Comprehensive Cancer Center UTSW

Location: NB5.124 Seminar Room and ZOOM

About Dr. Jaehyuk Choi:

Jaehyuk Choi, M.D., Ph.D. is a Professor of Dermatology and of the Simmons Comprehensive Cancer Center at UTSW. He is the inaugural director of the Center for Cellular Therapies and Cancer Immunology. An NIH-funded physician scientist, Dr. Choi has contributed to our understanding of the cellular and genetic bases of cutaneous lymphomas, reporting the first or the largest series of cutaneous CD4+ (MF, Sezary, and ATL), CD8+, CD4-CD8-, gamma delta, and multiple B cell lymphomas (diffuse large B cell and follicular). These studies have been published in Nature, Nature Cancer, Blood, amongst other journals. Collectively, they have identified clinically actionable biomarkers and therapeutic targets. His work has been recognized with the NIH New Innovator Award, the Damon Runyon Clinical Investigator Award, and the Mark Foundation Emerging Leader Award amongst others.

View on site | Email this event

Komen Breast Cancer Forum - Dr. Adrienne Boire, M.D., Ph.D., FAAN

Wednesday, July 15, 2026

"Innate Immunity Fuels Leptomeningeal Metastasis”

Speaker: Dr. Adrienne Boire, M.D., Ph.D., FAAN

Associate Attending, Department of Neurology

Memorial Sloan Kettering Cancer Center

Location: NB5.124 Seminar Room (In-person preferred) and ZOOM

About Dr. Adrienne Boire:

Dr. Boire is a neuro-oncologist who cares for patients with metastasis to the central nervous system. She has a special interest in leptomeningeal metastasis and leads a laboratory-based team conducting basic research to understand the molecular mechanisms responsible for this condition.

In collaboration with a multidisciplinary team of neurosurgeons, radiation oncologists, scientists, nurses, and research staff, she leads clinical trials that aim to translate laboratory research into novel therapies for patients with metastasis to the nervous system.

The Boire laboratory investigates the leptomeningeal space. The leptomeninges, layers of membranous coverings, encase the central nervous system and contain the circulating cerebrospinal fluid (CSF). In health, the leptomeninges maintain neural homeostasis and provide a route of biochemical communication between the periphery and the central nervous system. In disease, the leptomeningeal space plays host to a variety of pathologies, including autoimmunity, infectious disease, and malignancy.

Cancer cells may spread nearly anywhere in the body. When they enter into and grow within the leptomeningeal space, leptomeningeal metastasis (LM) results. This complication of cancer wreaks havoc with the homeostatic capacities of the CSF leading to neurological disabilities and death. We seek to understand neuroanatomically where and mechanistically how cancer cells become competent to enter into the leptomeninges. Once within the leptomeninges, cancer cells face profound metabolic challenges including low extracellular iron, hypoxia, and low extracellular lipid. The lab investigates how cancer cells overcome these metabolic constraints so that they may interrupt this signaling and arrest cancer cell growth in the space.

Although classically viewed as a barrier system, a more modern view of the leptomeninges is that of a conduit for biochemical and cellular communication between the systemic circulation and the central nervous system. Immune cells, their mediators, as well as signaling molecules generated from extra-CNS tissues are all detectable within the CSF. The lab investigates this signaling with the goal of understanding and ultimately interrupting neuro-pathological processes at the whole-organism level. This includes metastasis, autoimmunity, and infection.

View on site | Email this event

View on site | Email this event

View on site | Email this event